Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

The Impact of Age on the Outcome of Primary Treatment for Classical Hodgkin's Lymphoma: 70 Years of Age Is a Clinical Relevant Cutpoint and the Most Important Predictor of Overall Survival

Lourdes Calvente, MD, Manjula Maganti, MSc, Mary Gospodarowicz, MD FRCPC, David C. Hodgson, MD MPH, FRCPC, Danielle Rodin, MD MPH, FRCPC, Alexander Sun, MD FRCPC, Richard Tsang, MD FRCPC, Robert Kridel, MDMPH,PhD, Vishal Kukreti, MD, Anca Prica, MD, Michael Crump, MD FRCPC, John Kuruvilla, MD

Blood (2019) 134 (Supplement_1): 1559.

https://doi.org/10.1182/blood-2019-130282

Published: 2019

Journal Articles

A Single-Center Retrospective Study of 140 Patients with Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation

Michael D Jain, PhD MD, Ryan Lam, Rashmi S Goswami, MD, Krystyna Tybinkowski, Parneet K Cheema, MD, Atul Humar, MD MSc, Richard Tsang, MD, David Hodgson, MD, Anca Prica, MD, Vishal Kukreti, MD, Michael Crump, MD, John Kuruvilla, MD

Blood (2016) 128 (22): 4227.

https://doi.org/10.1182/blood.V128.22.4227.4227

Published: 2016

Journal Articles

Preliminary Results of FDG-PET Scanning after GDP Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Relapsed/Refractory (RR) Lymphoma

Matthew D. Cooper, Umberto Falcone, MD PhD, Naom Tau, MD, Eshetu G Atenafu, M.Sc., P.Stat., Richard Tsang, MD, David C. Hodgson, MD, Armand Keating, MD, Ur Metser, MD, Michael Crump, MD, John G. Kuruvilla, MD

Blood (2016) 128 (22): 4645.

https://doi.org/10.1182/blood.V128.22.4645.4645

Published: 2016

Journal Articles

Failure to Achieve CR with First-Line Treatment Is the Primary Cause of Treatment Failure in T-Cell Lymphoma: The Princess Margaret Cancer Centre Experience

Umberto Falcone, MD PhD, Melania Pintilie, MSc, Ri Wang, Vishal Kukreti, MD, John G. Kuruvilla, MD, Jan M.A. Delabie, MD PhD, Richard Tsang, MD, Michael Crump, MD

Blood (2016) 128 (22): 3005.

https://doi.org/10.1182/blood.V128.22.3005.3005

Published: 2016

Journal Articles

Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) Vs. Classical Hodgkin Lymphoma (cHL) at Princess Margaret Cancer Centre

Jeffery Ames, MD, Manjula Maganti, MSc, Bethany E Monteith, MD, David C. Hodgson, MD, Vishal Kukreti, MD, John G. Kuruvilla, MD, Anca Prica, MD, Richard Tsang, MD, Alex Sun, MD, Mary Gospodarowicz, MD, Melania Pintilie, MSc, Michael Crump, MD

Blood (2015) 126 (23): 3863.

https://doi.org/10.1182/blood.V126.23.3863.3863

Published: 2015

Journal Articles

Clinical Characteristics and Treatment Outcomes in Patients Diagnosed with Primary Mediastinal Large B-Cell Lymphoma at Princess Margaret Cancer Centre from 1994-2012

Anna M. Dyszkiewicz-Korpanty, MD PhD, Manjula Maganti, David C. Hodgson, MD, John G. Kuruvilla, MD, Vishal Kukreti, MD, Rodger E. Tiedemann, MD PhD, Alexander Sun, MD, Richard Tsang, MD, Mary Gospodarowicz, MD, Melania Pintilie, Anna Porwit, MDPhD, Michael Crump, MD

Blood (2014) 124 (21): 4447.

https://doi.org/10.1182/blood.V124.21.4447.4447

Published: 2014

Journal Articles

Follicular Lymphoma In Young Adults: Clinical Characteristics and Early Treatment Outcomes

Shane A Gangatharan, MBBS, FRACP, FRCPA, John Kuruvilla, MD, Vishal Kukreti, MD, FRCPC, Rodger E. Tiedemann, MBChB, PhD, FRACP, FRCPA, Mary Gospodarowicz, MD, David C. Hodgson, MD, Alex Sun, MD, Richard Tsang, MD, Manjula Maganti, Melania Pintilie, Michael Crump, MD FRCPC

Blood (2013) 122 (21): 4273.

https://doi.org/10.1182/blood.V122.21.4273.4273

Published: 2013

Journal Articles

Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)

Bouthaina S. Dabaja, MD, Richard Tsang, MD, Shunan Qi, Pamela Allen, PhD, David C. Hodgson, MD, Umberto Ricardi, MD, Richard T. Hoppe, MD, Andrea Ng, Lena Specht, Ye-xiong Li, MD, Stephanie Terezakis, MD, Louis Constine, MD, Joachim Yahalom, MD

Blood (2013) 122 (21): 4292.

https://doi.org/10.1182/blood.V122.21.4292.4292

Published: 2013

Journal Articles

Incidence and Predictors of Bleomycin Pulmonary Toxicity in Hodgkin Lymphoma (HL) Patients Treated with Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD),

Haowei (Linda) Sun, MD, Eshetu Atenafu, MSc, Richard Tsang, MD, Vishal Kukreti, MD, FRCPC, Michael Crump, MD, FRCPC, John Kuruvilla, MD, FRCPC

Blood (2011) 118 (21): 3643.

https://doi.org/10.1182/blood.V118.21.3643.3643

Published: 2011

Journal Articles

A Retrospective Study on the Incidence of Rituximab-Related Interstitial Pneumonitis In Patients Undergoing Immunochemotherapy for Non-Hodgkin Lymphoma

Giselle Salmasi, MD, Michael Li, BSc, Vithika Sivabalasundaram, BSc, Richard Tsang, MD, FRCPC, Vishal Kukreti, MD, FRCPC, Michael Crump, MD, FRCPC, John Kuruvilla, MD, FRCPC

Blood (2010) 116 (21): 3094.

https://doi.org/10.1182/blood.V116.21.3094.3094

Published: 2010

Journal Articles

Autologous Stem Cell Transplantion for Adolescents and Young Adults with Relapsed and Refractory Hodgkin Lymphoma

Muhammad Ali, MD, Tal Schechter, MD, Tony Panzarella, MSc, Diego Villa, MD, MPH, John Kuruvilla, MD, Vishal Kukreti, MD, Richard Tsang, MD, John J Doyle, MD, Michael Crump, MD

Blood (2010) 116 (21): 2402.

https://doi.org/10.1182/blood.V116.21.2402.2402

Published: 2010

Journal Articles

Outcomes of Second-Line Chemotherapy and Autologous Stem Cell Transplantation for Primary Refractory Diffuse Large B Cell Lymphoma

David Telio, MD, Clement Ma, MSc, Richard Tsang, MD, Armand Keating, MD, Michael Crump, MD, John Kuruvilla, MD

Blood (2008) 112 (11): 4445.

https://doi.org/10.1182/blood.V112.11.4445.4445

Published: 2008

Journal Articles

The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)

Blood (2008) 112 (11): 3608.

https://doi.org/10.1182/blood.V112.11.3608.3608

Published: 2008

Journal Articles

Primary Thyroid Lymphoma: A Retrospective IELSG and IIL Analysis of Clinical Characteristics, Prognostic Factors, Treatment Outcome and Somatic Hypermutation for Localized Diffuse Large B-Cell Lymphoma (DLBCL).

Blood (2007) 110 (11): 3432.

https://doi.org/10.1182/blood.V110.11.3432.3432

Published: 2007

Journal Articles

Second Cancers after Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma (NHL).

Tara Seshadri, MBBS, Melania Pintilie, MSc, Richard Tsang, MD, John Kuruvilla, MD, Sahar Zadeh, BSc, Armand Keating, MD, Michael Crump, MD

Blood (2007) 110 (11): 1673.

https://doi.org/10.1182/blood.V110.11.1673.1673

Published: 2007

Journal Articles

Extranodal Follicular Lymphoma - a Retrospective Review and Comparison with Localized Nodal Follicular Lymphoma.

Vishal Kukreti, MD, FRCPC, MSc, Peter Petersen, MD, PHD, Melania Pintilie, Richard Tsang, MD, FRCPC, Michael Crump, MD, FRCPC, Mary Gospodarowicz, MD, FRCPC, FRCR(HON)

Blood (2004) 104 (11): 1375.

https://doi.org/10.1182/blood.V104.11.1375.1375

Published: 2004

NARROW

The Impact of Age on the Outcome of Primary Treatment for Classical Hodgkin's Lymphoma: 70 Years of Age Is a Clinical Relevant Cutpoint and the Most Important Predictor of Overall Survival

A Single-Center Retrospective Study of 140 Patients with Post-Transplant Lymphoproliferative Disorder Following Solid Organ Transplantation

Preliminary Results of FDG-PET Scanning after GDP Chemotherapy Prior to Autologous Stem Cell Transplant (ASCT) for Relapsed/Refractory (RR) Lymphoma

Failure to Achieve CR with First-Line Treatment Is the Primary Cause of Treatment Failure in T-Cell Lymphoma: The Princess Margaret Cancer Centre Experience

Outcomes of Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) Vs. Classical Hodgkin Lymphoma (cHL) at Princess Margaret Cancer Centre

Clinical Characteristics and Treatment Outcomes in Patients Diagnosed with Primary Mediastinal Large B-Cell Lymphoma at Princess Margaret Cancer Centre from 1994-2012

Follicular Lymphoma In Young Adults: Clinical Characteristics and Early Treatment Outcomes

Either Combined-Modality Or Radiotherapy Alone Provide Favorable Outcome In Stage I-II Mantle Cell Lymphoma: A Report Of 82 Patients From The International Lymphoma Radiation Oncology Group (ILROG)

Incidence and Predictors of Bleomycin Pulmonary Toxicity in Hodgkin Lymphoma (HL) Patients Treated with Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD),

A Retrospective Study on the Incidence of Rituximab-Related Interstitial Pneumonitis In Patients Undergoing Immunochemotherapy for Non-Hodgkin Lymphoma

Autologous Stem Cell Transplantion for Adolescents and Young Adults with Relapsed and Refractory Hodgkin Lymphoma

Outcomes of Second-Line Chemotherapy and Autologous Stem Cell Transplantation for Primary Refractory Diffuse Large B Cell Lymphoma

The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)

Primary Thyroid Lymphoma: A Retrospective IELSG and IIL Analysis of Clinical Characteristics, Prognostic Factors, Treatment Outcome and Somatic Hypermutation for Localized Diffuse Large B-Cell Lymphoma (DLBCL).

Second Cancers after Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Relapsed/Refractory Aggressive Non-Hodgkin’s Lymphoma (NHL).

Extranodal Follicular Lymphoma - a Retrospective Review and Comparison with Localized Nodal Follicular Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only